Feng Ming Liu
Amministratore Delegato presso Changzhou Biowin Pharmaceutical Co., Ltd.
Posizioni attive di Feng Ming Liu
Società | Posizione | Inizio | Fine |
---|---|---|---|
Changzhou Biowin Pharmaceutical Co., Ltd.
Changzhou Biowin Pharmaceutical Co., Ltd. Medical SpecialtiesHealth Technology Changzhou Biowin Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and distribution of point-of-care diagnostic test kits (POCT). Its products include vitro diagnostic tools, Chinese patents and related applications for treating heart disease, infectious diseases, stroke, kidney function, diabetes, cancer, and bone metabolism disorders. The company also operates research laboratory, technology platforms, and response system for the development of emergency-use diagnostic product. Changzhou Biowin Pharmaceutical was founded on November 22, 2011 and is headquartered in Changzhou, China. | Amministratore Delegato | 01/01/2012 | - |
Presidente | 01/01/2012 | - | |
Direttore Tecnico/Scientifico/R&S | 01/01/2012 | - |
Storia della carriera di Feng Ming Liu
Precedenti posizioni note di Feng Ming Liu
Società | Posizione | Inizio | Fine |
---|---|---|---|
SHINECO, INC. | Amministratore Delegato | 03/08/2020 | - |
Direttore Tecnico/Scientifico/R&S | 03/08/2020 | - |
Formazione di Feng Ming Liu
Peking Union Medical College | Doctorate Degree |
Statistiche
Distribuzione geografica
Cina | 4 |
Posizioni
Chief Executive Officer | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Chairman | 1 |
Settori
Health Technology | 2 |
Process Industries | 2 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
SHINECO, INC. | Process Industries |
Aziende private | 1 |
---|---|
Changzhou Biowin Pharmaceutical Co., Ltd.
Changzhou Biowin Pharmaceutical Co., Ltd. Medical SpecialtiesHealth Technology Changzhou Biowin Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and distribution of point-of-care diagnostic test kits (POCT). Its products include vitro diagnostic tools, Chinese patents and related applications for treating heart disease, infectious diseases, stroke, kidney function, diabetes, cancer, and bone metabolism disorders. The company also operates research laboratory, technology platforms, and response system for the development of emergency-use diagnostic product. Changzhou Biowin Pharmaceutical was founded on November 22, 2011 and is headquartered in Changzhou, China. | Health Technology |
- Borsa valori
- Insiders
- Feng Ming Liu
- Esperienza